DK1405076T3 - Fremgangsmåde til diagnosticering eller prognosticering af væsentlige bakterielle patogener i luftvejene hos en patient - Google Patents
Fremgangsmåde til diagnosticering eller prognosticering af væsentlige bakterielle patogener i luftvejene hos en patientInfo
- Publication number
- DK1405076T3 DK1405076T3 DK02745164.0T DK02745164T DK1405076T3 DK 1405076 T3 DK1405076 T3 DK 1405076T3 DK 02745164 T DK02745164 T DK 02745164T DK 1405076 T3 DK1405076 T3 DK 1405076T3
- Authority
- DK
- Denmark
- Prior art keywords
- prognosticating
- diagnosing
- patient
- respiratory tract
- bacterial pathogens
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/5695—Mycobacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56944—Streptococcus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200100799 | 2001-05-18 | ||
| PCT/DK2002/000341 WO2002095411A1 (en) | 2001-05-18 | 2002-05-21 | A method of diagnosing or prognosticating major respiratory bacterial pathogens in a subject |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1405076T3 true DK1405076T3 (da) | 2011-01-03 |
Family
ID=8160511
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02745164.0T DK1405076T3 (da) | 2001-05-18 | 2002-05-21 | Fremgangsmåde til diagnosticering eller prognosticering af væsentlige bakterielle patogener i luftvejene hos en patient |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7399602B2 (da) |
| EP (1) | EP1405076B1 (da) |
| CN (1) | CN100340858C (da) |
| AT (1) | ATE479097T1 (da) |
| BR (1) | BRPI0210903B8 (da) |
| DE (1) | DE60237448D1 (da) |
| DK (1) | DK1405076T3 (da) |
| EA (1) | EA005776B1 (da) |
| ES (1) | ES2351690T3 (da) |
| WO (1) | WO2002095411A1 (da) |
| ZA (1) | ZA200309770B (da) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6902884B1 (en) | 1999-11-25 | 2005-06-07 | Virogates Aps | Method and tool for prognosticating HIV infection in a subject by measuring soluble urokinase plasminogen activator receptor, degradation products thereof, and urokinase plasminogen activator receptor |
| US20060084184A1 (en) * | 2004-10-19 | 2006-04-20 | Renovar Incorporated | Reagents for urine-based immunological assays |
| US8541179B2 (en) * | 2007-12-28 | 2013-09-24 | Bl Co., Ltd. | Immunodetection assay for Mycobacterium tuberculosis complex |
| KR101935072B1 (ko) | 2011-05-19 | 2019-01-03 | 모찌다 세이야쿠 가부시끼가이샤 | 오줌 검체를 사용한 호흡기 감염증의 진단 |
| GB201211982D0 (en) * | 2012-07-05 | 2012-08-22 | Isis Innovation | Biomarker |
| CN106461674A (zh) * | 2014-04-15 | 2017-02-22 | 斯坦陵布什大学 | 一种用于诊断结核性脑膜炎的方法 |
| WO2016020503A1 (en) * | 2014-08-08 | 2016-02-11 | Randox Laboratories Limited | Method and kit for detecting bacterial infection |
| CN106556703A (zh) * | 2016-10-18 | 2017-04-05 | 上海凯璟生物科技有限公司 | 一种慢性肾脏病标志物suPAR检测试剂盒和制备方法 |
| RU2659384C1 (ru) * | 2017-07-10 | 2018-06-29 | Федеральное государственное бюджетное учреждение "Детский научно-клинический центр инфекционных болезней Федерального медико-биологического агентства" | Способ раннего прогнозирования характера течения острой респираторной инфекции у детей |
| GB201802795D0 (en) * | 2018-02-21 | 2018-04-04 | Virogates As | Patient assessment method |
| FR3080185A1 (fr) * | 2018-04-16 | 2019-10-18 | Biomerieux | Evaluation du risque de complication chez un patient suspecte d'avoir une infection ayant un score sofa inferieur a deux |
| US20230236196A1 (en) * | 2020-04-08 | 2023-07-27 | Virogates A/S | Sars-cov-2 infection risk assessment method |
| RU2765744C2 (ru) * | 2020-07-20 | 2022-02-02 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Кировский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Кировский ГМУ Минздрава России) | Способ определения вероятности летального исхода на основании жалоб у больного туберкулезом с ВИЧ-инфекцией при поступлении в стационар Федеральной службы исполнения наказаний РФ |
| CN113295874B (zh) * | 2021-05-25 | 2022-03-04 | 广东源心再生医学有限公司 | 一种用于瓣膜性心脏病辅助诊断的新型标志物、辅助诊断的产品 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4845026A (en) * | 1985-12-03 | 1989-07-04 | T Cell Sciences, Inc. | Assay systems for detecting cell-free T cell antigen receptor related molecules and the clinical utilities of the assays |
| US5459078A (en) * | 1988-01-29 | 1995-10-17 | Abbott Laboratories | Methods and reagents for performing ion-capture digoxin assays |
| EP1051622A4 (en) | 1998-01-26 | 2001-12-19 | Biotech Australia Pty Ltd | PAI-2 AND T-PA USEFUL AS DIAGNOSTIC MARKERS OF PERIODONTOPATHY |
| US6077508A (en) * | 1998-03-23 | 2000-06-20 | American Diagnostica Inc. | Urokinase plasminogen activator receptor as a target for diagnosis of metastases |
| DE19840671A1 (de) | 1998-08-26 | 2000-03-02 | Stiftung Tumorbank Basel | Verfahren zur Diagnose von Rezidiven bei nodal-negativem Brustkrebs |
| AU4279900A (en) | 1999-04-28 | 2000-11-10 | Cardiogenics Inc. | Method for determining plasminogen activator inhibitor |
| US6902884B1 (en) | 1999-11-25 | 2005-06-07 | Virogates Aps | Method and tool for prognosticating HIV infection in a subject by measuring soluble urokinase plasminogen activator receptor, degradation products thereof, and urokinase plasminogen activator receptor |
-
2002
- 2002-05-21 CN CNB028122178A patent/CN100340858C/zh not_active Expired - Lifetime
- 2002-05-21 WO PCT/DK2002/000341 patent/WO2002095411A1/en not_active Application Discontinuation
- 2002-05-21 EA EA200301271A patent/EA005776B1/ru not_active IP Right Cessation
- 2002-05-21 AT AT02745164T patent/ATE479097T1/de active
- 2002-05-21 DE DE60237448T patent/DE60237448D1/de not_active Expired - Lifetime
- 2002-05-21 US US10/478,331 patent/US7399602B2/en not_active Expired - Lifetime
- 2002-05-21 ES ES02745164T patent/ES2351690T3/es not_active Expired - Lifetime
- 2002-05-21 DK DK02745164.0T patent/DK1405076T3/da active
- 2002-05-21 BR BRPI0210903A patent/BRPI0210903B8/pt not_active IP Right Cessation
- 2002-05-21 EP EP02745164A patent/EP1405076B1/en not_active Expired - Lifetime
-
2003
- 2003-12-17 ZA ZA200309770A patent/ZA200309770B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20050100961A1 (en) | 2005-05-12 |
| EP1405076B1 (en) | 2010-08-25 |
| ES2351690T3 (es) | 2011-02-09 |
| EP1405076A1 (en) | 2004-04-07 |
| WO2002095411A1 (en) | 2002-11-28 |
| BR0210903A (pt) | 2004-06-08 |
| US7399602B2 (en) | 2008-07-15 |
| EA200301271A1 (ru) | 2004-06-24 |
| BRPI0210903B8 (pt) | 2021-07-27 |
| ATE479097T1 (de) | 2010-09-15 |
| BRPI0210903B1 (pt) | 2017-01-17 |
| EA005776B1 (ru) | 2005-06-30 |
| ZA200309770B (en) | 2004-09-28 |
| CN100340858C (zh) | 2007-10-03 |
| CN1723394A (zh) | 2006-01-18 |
| DE60237448D1 (de) | 2010-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1405076T3 (da) | Fremgangsmåde til diagnosticering eller prognosticering af væsentlige bakterielle patogener i luftvejene hos en patient | |
| FI20021145A0 (fi) | Laitteisto elintoimintojen mittaamiseksi | |
| HK1087606A1 (en) | Sensor in vivo measurement of osmotic changes | |
| CY1110878T1 (el) | Διαδικασιες για την μετρηση της ισχυος του glatiramer acetate | |
| GB2381452B (en) | Wound monitoring | |
| HK1099363A1 (en) | Method for testing effect of angiogenesis inhibitor via integrin expression inhibition | |
| DK2204654T3 (da) | Anordninger og fremgangsmåder til detektering af fostervand i vaginalsekretioner | |
| NO996229D0 (no) | Heparanase spesifikke molekylaere prober og deres anvendelse i forskning og medisin | |
| NO20055692L (no) | Intravenos injeksjon av ikkeneurotoksiske plasminogenaktivatorer til behandling av cerebralt slag | |
| Pan et al. | Comparison of three measures of the ankle-brachial blood pressure index in a general population | |
| DE50310435D1 (de) | Filmförmige, zerfallsfähige zubereitungen zur wirkstoff-freisetzung und verfahren zu deren herstellung | |
| Hobbs et al. | The effect of supervised exercise and cilostazol on coagulation and fibrinolysis in intermittent claudication: a randomized controlled trial | |
| Ventetuolo et al. | Plasma endothelin-1 and vascular endothelial growth factor levels and their relationship to hemodynamics in idiopathic pulmonary fibrosis | |
| AP1623A (en) | A method of diagnosing of prognosticating HIV infection in a subject. | |
| BRPI0410467A (pt) | composições e métodos para tratamento de sìndrome respiratória aguda severa (sars) | |
| EA200400197A1 (ru) | Способы получения поливалентных бактериофагов для лечения бактериальных инфекций | |
| ATE304712T1 (de) | Thrombozyten-aktivierten vollblutgerinnungszeit | |
| NO20003766L (no) | PAI-2 og t-PA som diagnostiske markører for periodontal sykdom | |
| NO20072770L (no) | Anvendelse av en protease eller en proteasenhibitor for fremstilling av medikamenter | |
| DE602004029194D1 (de) | Methode zur messung der spezifizitat aktivierter lymphozyten | |
| DE60232069D1 (de) | Formen prostataspezifischer antigene und verfahren zu deren nachweis | |
| WO2002056666A3 (en) | A method of detecting ultrasound contrast agent in soft tissue, and quantitating blood perfusion through regions of tissue | |
| ATE335806T1 (de) | Diagnosisverfahren für whipples krankheit | |
| ATE422896T1 (de) | Eg-vegf/prokineticin 2 rezeptor antagonisten | |
| Sorensen et al. | Re: Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology |